{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:28:36Z","timestamp":1771504116918,"version":"3.50.1"},"reference-count":57,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CBRG\/0087\/2015"],"award-info":[{"award-number":["NMRC\/CBRG\/0087\/2015"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Although mammography is the gold standard for breast cancer screening, the high rates of false-positive mammograms remain a concern. Thus, there is an unmet clinical need for a non-invasive and reliable test to differentiate between malignant and benign breast lesions in order to avoid subjecting patients with abnormal mammograms to unnecessary follow-up diagnostic procedures. Serum samples from 116 malignant breast lesions and 64 benign breast lesions were comprehensively profiled for 2,083 microRNAs (miRNAs) using next-generation sequencing. Of the 180 samples profiled, three outliers were removed based on the principal component analysis (PCA), and the remaining samples were divided into training (n = 125) and test (n = 52) sets at a 70:30 ratio for further analysis. In the training set, significantly differentially expressed miRNAs (adjusted p &lt; 0.01) were identified after correcting for multiple testing using a false discovery rate. Subsequently, a predictive classification model using an eight-miRNA signature and a Bayesian logistic regression algorithm was developed. Based on the receiver operating characteristic (ROC) curve analysis in the test set, the model could achieve an area under the curve (AUC) of 0.9542. Together, this study demonstrates the potential use of circulating miRNAs as an adjunct test to stratify breast lesions in patients with abnormal screening mammograms.<\/jats:p>","DOI":"10.3390\/cancers11121872","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T10:57:27Z","timestamp":1574765847000},"page":"1872","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Circulating miRNA Signature for Stratification of Breast Lesions among Women with Abnormal Screening Mammograms"],"prefix":"10.3390","volume":"11","author":[{"given":"Sau Yeen","family":"Loke","sequence":"first","affiliation":[{"name":"Cellular and Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore 169610, Singapore"},{"name":"SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhakaran","family":"Munusamy","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geok Ling","family":"Koh","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire Hian Tzer","family":"Chan","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preetha","family":"Madhukumar","sequence":"additional","affiliation":[{"name":"SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Division of Surgical Oncology, National Cancer Centre, Singapore 169610, Singapore"},{"name":"Department of General Surgery, Singapore General Hospital, Singapore 169608, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Liang","family":"Thung","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, National Cancer Centre, Singapore 169610, Singapore"},{"name":"SingHealth Duke-NUS Breast Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiat Tee Benita","family":"Tan","sequence":"additional","affiliation":[{"name":"SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Division of Surgical Oncology, National Cancer Centre, Singapore 169610, Singapore"},{"name":"Department of General Surgery, Singapore General Hospital, Singapore 169608, Singapore"},{"name":"SingHealth Duke-NUS Breast Centre, Singapore 169610, Singapore"},{"name":"Department of General Surgery, Sengkang General Hospital, Singapore 544886, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kong Wee","family":"Ong","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, National Cancer Centre, Singapore 169610, Singapore"},{"name":"SingHealth Duke-NUS Breast Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Sean","family":"Yong","sequence":"additional","affiliation":[{"name":"SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Division of Surgical Oncology, National Cancer Centre, Singapore 169610, Singapore"},{"name":"Department of General Surgery, Singapore General Hospital, Singapore 169608, Singapore"},{"name":"SingHealth Duke-NUS Breast Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8758-0455","authenticated-orcid":false,"given":"Yirong","family":"Sim","sequence":"additional","affiliation":[{"name":"SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Division of Surgical Oncology, National Cancer Centre, Singapore 169610, Singapore"},{"name":"SingHealth Duke-NUS Breast Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Lie","family":"Oey","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, National Cancer Centre, Singapore 169610, Singapore"},{"name":"SingHealth Duke-NUS Breast Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue Zann","family":"Lim","sequence":"additional","affiliation":[{"name":"SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Division of Surgical Oncology, National Cancer Centre, Singapore 169610, Singapore"},{"name":"Department of General Surgery, Singapore General Hospital, Singapore 169608, Singapore"},{"name":"SingHealth Duke-NUS Breast Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mun Yew Patrick","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng Swan Juliana","family":"Ho","sequence":"additional","affiliation":[{"name":"SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Division of Oncologic Imaging, National Cancer Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boon Kheng James","family":"Khoo","sequence":"additional","affiliation":[{"name":"SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Division of Oncologic Imaging, National Cancer Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Lin Jill","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Oncologic Imaging, National Cancer Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choon Hua","family":"Thng","sequence":"additional","affiliation":[{"name":"SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Division of Oncologic Imaging, National Cancer Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bee Kiang","family":"Chong","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore 308433, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ern Yu","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique Kiak-Mien","family":"Tan","sequence":"additional","affiliation":[{"name":"SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Division of Surgical Oncology, National Cancer Centre, Singapore 169610, Singapore"},{"name":"Department of General Surgery, Singapore General Hospital, Singapore 169608, Singapore"},{"name":"SingHealth Duke-NUS Breast Centre, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9719-9332","authenticated-orcid":false,"given":"Ann Siew Gek","family":"Lee","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore 169610, Singapore"},{"name":"SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"},{"name":"Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1377\/hlthaff.2014.1087","article-title":"National expenditure for false-positive mammograms and breast cancer overdiagnoses estimated at $4 billion a year","volume":"34","author":"Ong","year":"2015","journal-title":"Health Aff. (Millwood)"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13058-019-1109-0","article-title":"Exosomal mirna profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy","volume":"21","author":"Ortega","year":"2019","journal-title":"Breast Cancer Re."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1148\/radiographics.18.5.9747612","article-title":"The false-negative mammogram","volume":"18","author":"Huynh","year":"1998","journal-title":"Radiographics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1148\/radiol.2251011667","article-title":"Comparison of the performance of screening mammography, physical examination, and breast us and evaluation of factors that influence them: An analysis of 27,825 patient evaluations","volume":"225","author":"Kolb","year":"2002","journal-title":"Radiology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/M15-0971","article-title":"Factors associated with rates of false-positive and false-negative results from digital mammography screening: An analysis of registry data","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7326\/0003-4819-155-8-201110180-00004","article-title":"Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: A cohort study","volume":"155","author":"Hubbard","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41698-017-0039-5","article-title":"The potential of liquid biopsies for the early detection of cancer","volume":"1","author":"Heitzer","year":"2017","journal-title":"NPJ Precis. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000089260","article-title":"Tumor markers in breast cancer\u2014european group on tumor markers recommendations","volume":"26","author":"Molina","year":"2005","journal-title":"Tumour Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/JOP.0768504","article-title":"American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer","volume":"3","author":"Harris","year":"2007","journal-title":"J. Oncol. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejca.2017.12.025","article-title":"The future of blood-based biomarkers for the early detection of breast cancer","volume":"92","author":"Loke","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","article-title":"Clinical relevance of circulating cell-free micrornas in cancer","volume":"11","author":"Schwarzenbach","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Peng, Y., and Croce, C.M. (2016). The role of micrornas in human cancer. Signal. Transduct Target Ther., 1.","DOI":"10.1038\/sigtrans.2015.4"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"Micrornas in cancer: Biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1038\/sj.onc.1209913","article-title":"A small piece in the cancer puzzle: Micrornas as tumor suppressors and oncogenes","volume":"25","author":"Kent","year":"2006","journal-title":"Oncogene"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.gene.2016.01.042","article-title":"Study of micrornas-21\/221 as potential breast cancer biomarkers in egyptian women","volume":"590","author":"Motawi","year":"2016","journal-title":"Gene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10549-012-1988-6","article-title":"Diagnostic potential of pten-targeting mir-214 in the blood of breast cancer patients","volume":"134","author":"Schwarzenbach","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Cuk, K., Zucknick, M., Madhavan, D., Schott, S., Golatta, M., Heil, J., Marme, F., Turchinovich, A., Sinn, P., and Sohn, C. (2013). Plasma microrna panel for minimally invasive detection of breast cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076729"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Klein, E.A., Hubbell, E., Maddala, T., Aravanis, A., Beausang, J.F., Filippova, D., Gross, S., Jamshidi, A., Kurtzman, K., and Shen, L. (2018). Development of a comprehensive cell-free DNA (cfdna) assay for early detection of multiple tumor types: The circulating cell-free genome atlas (ccga) study. J. Clin. Oncol., 36.","DOI":"10.1200\/JCO.2018.36.15_suppl.12021"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Liu, M.C., Maddala, T., Aravanis, A., Hubbell, E., Beausang, J.F., Filippova, D., Gross, S., Jamshidi, A., Kurtzman, K., and Shen, L. (2018). Breast cancer cell-free DNA (cfdna) profiles reflect underlying tumor biology: The circulating cell-free genome atlas (ccga) study. J. Clin. Oncol., 36.","DOI":"10.1200\/JCO.2018.36.15_suppl.536"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1007\/s13277-014-2375-1","article-title":"Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: Can their ratio improve the results?","volume":"35","author":"Attallah","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/1078-0432.CCR-15-0654","article-title":"Identification of developmental endothelial locus-1 on circulating extracellular vesicles as a novel biomarker for early breast cancer detection","volume":"22","author":"Moon","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/iub.1346","article-title":"Aberrant methylation of apc and rarbeta2 genes in breast cancer patients","volume":"67","author":"Swellam","year":"2015","journal-title":"IUBMB Life"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cas.12880","article-title":"Novel combination of serum microrna for detecting breast cancer in the early stage","volume":"107","author":"Shimomura","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrg3198","article-title":"Microrna profiling: Approaches and considerations","volume":"13","author":"Pritchard","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"83940","DOI":"10.18632\/oncotarget.20806","article-title":"Measuring plasma levels of three micrornas can improve the accuracy for identification of malignant breast lesions in women with bi-rads 4 mammography","volume":"8","author":"Pezuk","year":"2017","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12321","DOI":"10.1002\/jcb.28496","article-title":"Clinical significance of blood-based mirnas as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers","volume":"120","author":"Swellam","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_28","first-page":"1389","article-title":"A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection","volume":"9","author":"Wang","year":"2016","journal-title":"Onco. Targets Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36622","DOI":"10.18632\/oncotarget.9124","article-title":"Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"13848","DOI":"10.18632\/oncotarget.24486","article-title":"Ctbp1 and metabolic syndrome induce an mrna and mirna expression profile critical for breast cancer progression and metastasis","volume":"9","author":"Farre","year":"2018","journal-title":"Oncotarget"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Aure, M.R., Leivonen, S.K., Fleischer, T., Zhu, Q., Overgaard, J., Alsner, J., Tramm, T., Louhimo, R., Alnaes, G.I., and Perala, M. (2013). Individual and combined effects of DNA methylation and copy number alterations on mirna expression in breast tumors. Genome Biol., 14.","DOI":"10.1186\/gb-2013-14-11-r126"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ding, J., Wu, W., Yang, J., and Wu, M. (2019). Long non-coding rna mif-as1 promotes breast cancer cell proliferation, migration and emt process through regulating mir-1249-3p\/hoxb8 axis. Pathol. Res. Pract., 215.","DOI":"10.1016\/j.prp.2019.03.005"},{"key":"ref_33","first-page":"1324","article-title":"Microrna mir-1249 downregulates adenomatous polyposis coli 2 expression and promotes glioma cells proliferation","volume":"10","author":"Fang","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41419-018-1188-3","article-title":"P53-induced mir-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting vegfa and hmga2","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_35","first-page":"719","article-title":"Microrna profiles to predict postoperative prognosis in patients with small cell carcinoma of the esophagus","volume":"35","author":"Okumura","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3892\/ol.2012.810","article-title":"Identification of pathogenesis-related micrornas in hepatocellular carcinoma by expression profiling","volume":"4","author":"Katayama","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yexcr.2017.03.010","article-title":"Induced mir-1249 expression by aberrant activation of hedegehog signaling pathway in hepatocellular carcinoma","volume":"355","author":"Ye","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1002\/jcp.26316","article-title":"Microrna-6869-5p acts as a tumor suppressor via targeting tlr4\/nf-kappab signaling pathway in colorectal cancer","volume":"233","author":"Yan","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3892\/ijmm.2013.1424","article-title":"Serum microrna expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma","volume":"32","author":"Chen","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/2159-8290.CD-14-1057","article-title":"A large-scale analysis of genetic variants within putative mirna binding sites in prostate cancer","volume":"5","author":"Stegeman","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1373\/clinchem.2018.295824","article-title":"Microrna-3162-5p-mediated crosstalk between kallikrein family members including prostate-specific antigen in prostate cancer","volume":"65","author":"Matin","year":"2019","journal-title":"Clin. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ejhf.950","article-title":"Serially measured circulating micrornas and adverse clinical outcomes in patients with acute heart failure","volume":"20","author":"Kardys","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ejhf.984","article-title":"Prognostic value of circulating micrornas on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients","volume":"20","author":"Lanfear","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1167\/iovs.18-24878","article-title":"Identification of candidate mirna biomarkers for glaucoma","volume":"60","author":"Hindle","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.18632\/oncotarget.13744","article-title":"Altered microrna profiles in plasma exosomes from mesial temporal lobe epilepsy with hippocampal sclerosis","volume":"8","author":"Yan","year":"2017","journal-title":"Oncotarget"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Hasan, M.M., Akter, R., Ullah, M.S., Abedin, M.J., Ullah, G.M., and Hossain, M.Z. (2014). A computational approach for predicting role of human micrornas in mers-cov genome. Adv. Bioinformatics, 2014.","DOI":"10.1155\/2014\/967946"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Elias, K.M., Fendler, W., Stawiski, K., Fiascone, S.J., Vitonis, A.F., Berkowitz, R.S., Frendl, G., Konstantinopoulos, P., Crum, C.P., and Kedzierska, M. (2017). Diagnostic potential for a serum mirna neural network for detection of ovarian cancer. Elife, 6.","DOI":"10.7554\/eLife.28932"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12943-017-0726-4","article-title":"Identification of non-invasive mirnas biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes","volume":"16","author":"Rodriguez","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Tiberio, P., Callari, M., Angeloni, V., Daidone, M.G., and Appierto, V. (2015). Challenges in using circulating mirnas as cancer biomarkers. BioMed Res. Int., 2015.","DOI":"10.1155\/2015\/731479"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Leidner, R.S., Li, L., and Thompson, C.L. (2013). Dampening enthusiasm for circulating microrna in breast cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057841"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1373\/clinchem.2014.221341","article-title":"Circulating microrna biomarker studies: Pitfalls and potential solutions","volume":"61","author":"Witwer","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2016.07.002","article-title":"Circulating micrornas in cancer: Hope or hype?","volume":"381","author":"Singh","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.5858\/arpa.2018-0901-SA","article-title":"Circulating tumor DNA analysis in patients with cancer: American society of clinical oncology and college of american pathologists joint review","volume":"142","author":"Merker","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jncimonographs\/lgq035","article-title":"Ductal carcinoma in situ: Terminology, classification, and natural history","volume":"2010","author":"Allred","year":"2010","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1634\/theoncologist.11-5-435","article-title":"Benign breast diseases: Classification, diagnosis, and management","volume":"11","author":"Guray","year":"2006","journal-title":"Oncologist"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-143-6-200509200-00009","article-title":"Premalignant and in situ breast disease: Biology and clinical implications","volume":"143","author":"Arpino","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and dispersion for rna-seq data with deseq2. Genome Biol., 15.","DOI":"10.1186\/s13059-014-0550-8"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/12\/1872\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:37:38Z","timestamp":1760189858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/12\/1872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["cancers11121872"],"URL":"https:\/\/doi.org\/10.3390\/cancers11121872","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]}}}